Literature DB >> 15982444

Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS).

Antonio Mantovani1, Sarah H Lisanby, Fulvio Pieraccini, Monica Ulivelli, Paolo Castrogiovanni, Simone Rossi.   

Abstract

There is evidence that motor and premotor cortex are hyperexcitable in obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS). We tested whether low-frequency repetitive transcranial magnetic stimulation (rTMS) could normalize overactive motor cortical regions and thereby improve symptoms. Subjects with OCD or TS were treated with active rTMS to the supplementary motor area (SMA) for 10 daily sessions at 1 Hz, 100% of motor threshold, 1200 stimuli/day. Suggestions of clinical improvement were apparent as early as the first week of rTMS. At the second week of treatment, statistically significant reductions were seen in the YBOCS, YGTSS, CGI, HARS, HDRS, SAD, BDI, SCL-90, and SASS. Symptoms improvement was correlated with a significant increase of the right resting motor threshold and was stable at 3 months follow-up. Slow rTMS to SMA resulted in a significant clinical improvement and a normalization of the right hemisphere hyperexcitability, thereby restoring hemispheric symmetry in motor threshold.

Entities:  

Mesh:

Year:  2005        PMID: 15982444     DOI: 10.1017/S1461145705005729

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  71 in total

Review 1.  Neurobiological substrates of Tourette's disorder.

Authors:  James F Leckman; Michael H Bloch; Megan E Smith; Daouia Larabi; Michelle Hampson
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-08       Impact factor: 2.576

2.  Tourette syndrome associated with attention deficit hyperactivity disorder: The impact of tics and psychopharmacological treatment options.

Authors:  Olumide O Oluwabusi; Susan Parke; Paul J Ambrosini
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 3.  Emerging treatments for Tourette's disorder.

Authors:  Michael H Bloch
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

4.  Reduced functional connectivity within the limbic cortico-striato-thalamo-cortical loop in unmedicated adults with obsessive-compulsive disorder.

Authors:  Jonathan Posner; Rachel Marsh; Tiago V Maia; Bradley S Peterson; Allison Gruber; H Blair Simpson
Journal:  Hum Brain Mapp       Date:  2013-09-30       Impact factor: 5.038

Review 5.  Neuromodulation for obsessive-compulsive disorder.

Authors:  Kyle A B Lapidus; Emily R Stern; Heather A Berlin; Wayne K Goodman
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 6.  Transcranial cortical stimulation in the treatment of obsessive-compulsive disorders: efficacy studies.

Authors:  Ghassen Saba; Albert Moukheiber; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2015-05       Impact factor: 5.285

Review 7.  Review of structural neuroimaging in patients with refractory obsessive-compulsive disorder.

Authors:  Murad Atmaca
Journal:  Neurosci Bull       Date:  2011-06       Impact factor: 5.203

Review 8.  The management of tics.

Authors:  David Shprecher; Roger Kurlan
Journal:  Mov Disord       Date:  2009-01-15       Impact factor: 10.338

9.  Randomized Sham Controlled Double-blind Trial of Repetitive Transcranial Magnetic Stimulation for Adults With Severe Tourette Syndrome.

Authors:  Angeli Landeros-Weisenberger; Antonio Mantovani; Maria G Motlagh; Pedro Gomes de Alvarenga; Liliya Katsovich; James F Leckman; Sarah H Lisanby
Journal:  Brain Stimul       Date:  2014-12-03       Impact factor: 8.955

10.  Augmentation effect of repetitive transcranial magnetic stimulation over the orbitofrontal cortex in drug-resistant obsessive-compulsive disorder patients: a controlled investigation.

Authors:  Chiara Ruffini; Marco Locatelli; Adelio Lucca; Francesco Benedetti; Chiara Insacco; Enrico Smeraldi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.